Company signals
TailorMed
2 signals in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Backdrop: a 97.6 (Neutral) Talent Market Index (down 3.4 on the month) with Americas activity easing (-15.6pts).
TailorMed: 2 signals in the last 90 days; 2 tracked across 8 days.
Signals at TailorMed
M&A Activity
AmericasTailorMed, a US medication access and adherence platform, announced a majority investment from New York-based growth private equity firm GrowthCurve Capital to fund continued growth and AI-powered solutions.
Leadership read: Consolidation shifts the leadership question from growth to integration. For TailorMed in the sector, the demand moves toward transformation and integration leaders who can merge teams, systems and cultures without losing momentum. Across Americas, watch whether the integration is properly resourced; deals are won or lost the year after they close.
curated · 2026-11-10 · context →
Capital Raising
AmericasTailorMed secured a majority private equity investment from New York-based GrowthCurve Capital to scale its AI-enabled medication access platform and expand across hospitals, clinics, pharmacies and life sciences manufacturers.
Leadership read: TailorMed's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-11-02 · context →
TailorMed signals in the last 90 days
2 public signals observed since 16 August 2026, by type.
More signals across Americas
Capital Raising · Americas
Adherium (ASX:ADR) →Adherium is relying on shareholder-linked loans to fund its US digital respiratory monitoring business, a financing signal rather than an equity raise.
Capital Raising · Americas
Skribe Medical →US medtech startup Skribe Medical raised a US$1.65M pre-seed round led by SeaX Ventures with GoAhead Ventures and Marin Sonoma Impact Ventures; its Aurora AI heart patch was selected for the FDA READI-Home Innovation Challenge and NOECHO trial has enrolled 800+ patients across US and Southeast Asian sites.
Capital Raising · Americas
Operand →Operand, a New York City-based AI due diligence startup serving private equity, raised $31M across Seed and Series A at a $220M valuation, led by Khosla Ventures with Felicis, SV Angel, Soma Capital and Y Combinator participating.
Capital Raising · Americas
EPR Properties →EPR Properties has priced a $500 million convertible notes offering.
Capital Raising · Americas
PortX →PortX, a Seattle-based AI-native data integration platform for community banks and credit unions, secured growth capital financing led by CIBC Innovation Banking to support growth and product development.
Capital Raising · Americas
Northside Ventures →Toronto-based early-stage VC Northside Ventures has launched its second fund, targeting US$30M (C$40M) by early 2027, with US$17M in commitments already secured across two closes. Anchor LPs include CIBC Innovation Banking, Intact Private Capital and TD Innovation Partners, alongside Bain Capital Ventures.
Where TailorMed's market lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
- Data period
- 2 Nov 2026 – 10 Nov 2026 · 2 signals for this company
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated